We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$86.9B
AUM Growth
+$1.22B
Cap. Flow
-$8.13B
Cap. Flow %
-9.35%
Top 10 Hldgs %
9.21%
Holding
2,795
New
93
Increased
976
Reduced
1,389
Closed
209

Top Sells

Rank Stock Value
1
Y
Alleghany Corp
Y
+$504M
2
ADM icon
Archer Daniels Midland
ADM
+$183M
3
CDW icon
CDW
CDW
+$150M
4
CTVA icon
Corteva
CTVA
+$146M
5
SBAC icon
SBA Communications
SBAC
+$144M

Sector Composition

Rank Sector Weight
1 Technology 16%
2 Industrials 14.52%
3 Financials 13.87%
4 Healthcare 10.7%
5 Consumer Discretionary 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPPI
2526
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$7K ﹤0.01%
19,006
-7
-0% -$3
CNVS icon
2527
Cineverse
CNVS
$65.6M
$6.71K ﹤0.01%
865
POL
2528
DELISTED
Polished.com Inc.
POL
$6.63K ﹤0.01%
230
ML
2529
DELISTED
MoneyLion Inc.
ML
$6.6K ﹤0.01%
+355
New +$8.74K
TALK icon
2530
Talkspace
TALK
$874M
$6.57K ﹤0.01%
10,771
-4
-0% -$3
VGZ icon
2531
Vista Gold
VGZ
$308M
$6.37K ﹤0.01%
12,870
-5
-0% -$3
JOB icon
2532
GEE Group
JOB
$22.5M
$5.96K ﹤0.01%
12,173
-3
-0% -$2
ADVM
2533
DELISTED
Adverum Biotechnologies
ADVM
$5.95K ﹤0.01%
1,026
DAVE icon
2534
Dave Inc
DAVE
$4.06B
$5.69K ﹤0.01%
613
LIDR icon
2535
AEye
LIDR
$61.1M
$5.65K ﹤0.01%
392
UAMY icon
2536
United States Antimony
UAMY
$1.02B
$5.05K ﹤0.01%
10,369
-3
-0% -$1
WGS icon
2537
GeneDx Holdings
WGS
$2.3B
$4.9K ﹤0.01%
563
SDC
2538
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$4.65K ﹤0.01%
13,204
-5
-0% -$3
PRTY
2539
DELISTED
Party City Holdco Inc.
PRTY
$4.41K ﹤0.01%
12,055
-4
-0% -$4
VLTA
2540
DELISTED
Volta Inc.
VLTA
$4.08K ﹤0.01%
11,472
-4
-0% -$3
IMDX
2541
Insight Molecular Diagnostics
IMDX
$156M
$4.02K ﹤0.01%
626
GPUS
2542
Hyperscale Data Inc
GPUS
$55.4M
0
AUMN
2543
DELISTED
Golden Minerals Company
AUMN
$3.96K ﹤0.01%
578
CATX icon
2544
Perspective Therapeutics
CATX
$342M
$3.94K ﹤0.01%
1,596
-1
-0.1% -$3
LITS
2545
Lite Strategy Inc
LITS
$30.9M
$3.35K ﹤0.01%
688
AUD
2546
DELISTED
Audacy, Inc.
AUD
$2.96K ﹤0.01%
13,149
-428,077
-97% -$135K
DMK
2547
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$2.85K ﹤0.01%
241
OIG
2548
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$2.8K ﹤0.01%
355
+76
+27% +$872
INUV icon
2549
Inuvo
INUV
$17M
$2.6K ﹤0.01%
1,173
BIOR
2550
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$2.48K ﹤0.01%
75

Similar funds

Victory Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Victory Capital Management held 2,795 positions worth $86.9B, up 1.4% from $85.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Victory Capital Management withdrew a net $8.13B in Q4 2022, closing 209 positions and reducing 1,389 holdings. Its most notable exit was Alleghany Corp, an estimated $504M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.

Against the trend, Victory Capital Management opened a new position in VictoryShares WestEnd US Sector ETF worth $140M.

  • Victory Capital Management's largest Q4 2022 buy was VictoryShares WestEnd US Sector ETF: 5,259,612 shares worth $140M.
  • Victory Capital Management added most to T. Rowe Price in Q4 2022, an estimated $213M increase.
  • Victory Capital Management's biggest Q4 2022 reduction was Archer Daniels Midland, cutting an estimated $183M.
  • Victory Capital Management fully exited Alleghany Corp in Q4 2022, selling an estimated $504M.
  • Victory Capital Management's ten largest holdings make up 9.2% of its $86.9B portfolio in Q4 2022.
  • Victory Capital Management opened 93 new positions and closed 209 in Q4 2022.
  • Victory Capital Management's portfolio value rose 1.4% quarter-over-quarter to $86.9B.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.